publication venue for
- Rapid chloride and bicarbonate determination by capillary electrophoresis for confirmatory testing of cystic fibrosis infants with volume-limited sweat specimens. 22:66-72. 2023
- P122 Identification and characterisation of a Liverpool Epidemic Strain (LES) isolate of Pseudomonas aeruginosa, first collected in 1986 in Calgary, Canada. 21:S98-S98. 2022
- ePS3.09 Methicillin-sensitive Staphylococcus aureus (MSSa) with inoculum-related reduced susceptibility to cefazolin (CZ) and piperacillintazobactam (TZP) in persons with cystic fibrosis (pwCF). 21:S51-S52. 2022
- Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies. 21:282-292. 2022
- Infant spirometry as a predictor of lung function at early childhood in cystic fibrosis patients. 20:937-940. 2021
- Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis. 19:119-124. 2020
- The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome. 18:829-837. 2019
- EPS3.04 Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation. 17:S42-S42. 2018
- Effect of freezing sputum on Pseudomonas aeruginosa population heterogeneity. 16:353-357. 2017
- Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation. 15:392-399. 2016
- Understanding the natural history and clinical implications of airways infections in CF — Moving beyond the classics. 15:270-271. 2016
- Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. 14:755-762. 2015
- Alternative outcomes for the multiple breath washout in children with CF. 14:490-496. 2015
- Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. 14:262-266. 2015
- Reduced fat oxidation rates during submaximal exercise in boys with cystic fibrosis. 13:92-98. 2014
- 85 Investigation into the antibiotic resistome of the Streptococcus genus from adult cystic fibrosis patients. 12:S70-S70. 2013
- WS18.3 A twenty-five year outbreak of Pseudomonas aeruginosa: identification of the Prairie Epidemic Strain (PES). 11:S41-S41. 2012
- Inflammatory and growth factor response to continuous and intermittent exercise in youth with cystic fibrosis. 11:108-118. 2012
- Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. 1:31-34. 2002